Jennifer Viera

Jennifer Viera is an accomplished communications and investor relations professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Executive Director of Investor Relations and Corporate Communications at Enanta Pharmaceuticals since February 2020, Jennifer previously held senior positions at Tetraphase Pharmaceuticals, OvaScience, The Seismic Collaborative, and Viera Communications, among others. Notable achievements include leading the launch of XERAVA, managing investor and public relations for multiple organizations, and enhancing corporate visibility for key products such as VIVITROL. Jennifer holds a B.A. in Communications and Psychology from Boston College, graduating summa cum laude.